Navigation Links
Cardiac Science Launches 'Anywhere' Data Management for HIS and EMR Systems

Pyramis(R), the flagship HeartCentrix(R) data management product for the hospital market, works anywhere there is a secure Internet connection

BOTHELL, Wash., June 16 /PRNewswire-FirstCall/ -- Cardiac Science today announced the launch of Pyramis(R) 6.2, the flagship HeartCentrix(R) data management product for the hospital market. Pyramis 6.2 centralizes diagnostic cardiology data for rapid access across all facilities within a hospital network. Cardiac Science (Nasdaq: CSCX) is a global leader in advanced cardiac diagnosis, resuscitation, rehabilitation, and informatics products.


"Hospitals love the remote access features," said Rene Mitchell, director of diagnostic marketing for Cardiac Science. "And they don't have to invest in custom connectivity software or hardware, since Pyramis 6.2 communicates with all Health Level 7 (HL7) interfaces on an open architecture, thus reducing hospital expenditures."

Pyramis is multi-modal. It supports hospitals' preferred electrocardiogram devices (ECGs), stress testing equipment, Holter monitors, and other devices on a single platform -- and provides bi-directional communication when paired with most Quinton(R) and Burdick(R) devices. Pyramis 6.2:

-- Improves patient care, because it removes many manual steps which slow

down the care-giving process in ECG, stress, Holter, and other


-- Saves time, because patient demographics and orders are downloaded

directly into the cardiac monitoring mode of choice;

-- Eliminates transcription errors, since everything is electronically

transmitted and physician over reads are transmitted directly into the

patient file; and,

-- Reduces billing errors, because it uses a patient's enterprise

identification number (EIN) so bills don't get lost or misfiled.

Among ECG management systems, Pyramis provides a unique-to-the-industry feature: Digital Imaging and Communications in Medicine (DICOM) images can be sent to Picture Archiving and Communication Systems (PACS) and Hospital Information Systems (HIS) so end users can review not just single but multi- modality recordings (ECG, stress, and Holter) in one application.

Stephen French, program manager-PACS for WellSpan Health of Pennsylvania, switched from GE MUSE to Pyramis. He explained, "We needed a stable system for new and current hardware. Pyramis is better for ECG and stress tests on a single system, and waveforms and stress tests are "waveform enabled" and viewable via Millennium (Cerner's HIS system). With Pyramis, we have remote access via any Wellspan access device -- and remote access at home for all clinicians."

"Along with the rest of the HeartCentrix connectivity products, Pyramis reinforces our commitment to the markets we serve: Everything Cardiac Science makes needs to connect to your systems to save you money, eliminate implementation headaches, and help you provide better patient care," added Tony Titus, vice president of marketing for Cardiac Science.

Pyramis can be purchased as a software-only option, and provides important clinical workflow tools including electronic signature, calipers, serial comparison, prior tests accessibility, order attachment, multi-faceted patient and test queries, tests status, overdue indicators, and data mining tools, among others.

For more information,

Company Contact:

Mike Matysik

Cardiac Science Corporation

Sr. Vice President and CFO


Investor Contact:

Jenifer Kirtland

EVC Group, Inc.


Media Contact:

Christopher Gale

EVC Group, Inc.



About Cardiac Science

Cardiac Science develops, manufactures, and markets a family of advanced diagnostic and therapeutic cardiology devices and systems, including automated external defibrillators (AEDs), electrocardiograph devices (ECGs), cardiac stress systems and treadmills, Holter monitoring systems, hospital defibrillators, cardiac rehabilitation telemetry systems, and cardiology data management systems (informatics) that connect with hospital information (HIS), electronic medical record (EMR), and other information systems. The Company sells a variety of related products and consumables, and provides a portfolio of training, maintenance, and support services. Cardiac Science, the successor to the cardiac businesses that established the trusted Burdick(R), HeartCentrix(R), Powerheart(R), and Quinton(R) brands, is headquartered in Bothell, Washington. With customers in more than 100 countries worldwide, the company has operations in North America, Europe, and Asia. For information, call 425.402.2000 or visit

Forward-Looking Statements

This press release contains forward-looking statements including, but not limited to, those that infer that Cardiac Science Corporation's future revenue and profits may grow as a result of sales of Pyramis and the HeartCentrix suite of connectivity products. These statements and their underlying assumptions involve a number of risks and uncertainties and are not guarantees of future performance. These are forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. The words "believe," "expect," "intend," anticipate," variations of such words, and similar expressions identify forward-looking statements, but their absence does not mean that the statement is not forward looking. Actual results may vary significantly from the results expressed or implied in such statements. Factors that could cause or contribute to such varying results and other risks that are more fully described in the Annual Report on Form 10-K filed by Cardiac Science Corporation for the year ended December 31, 2007. Cardiac Science Corporation undertakes no duty or obligation to update the information provided herein.


SOURCE Cardiac Science Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Braemar Introduces the ER920W Wireless Cardiac Arrhythmia Monitor
2. Cardiac Science to Present at Needham Biotechnology & Medical Technology Conference
3. Perceptive Informatics Enhances Medical Imaging Capabilities for Assessment of Cardiac Function
4. Increased Drug Related Cardiac Toxicity Leads Gwathmey Preclinical Testing Services to Create Novel Cardionomics(TM) Services for Preclinical Cardiac Safety Screening of Drug Candidates
5. CorMatrix(R) Announces FDA 510(k) for Novel Biomaterial Implant for Intracardiac Repair
6. CryoLife Conducts Surgeons Cardiac Allograft Symposium
7. Cardiac Science Schedules First Quarter Earnings Release and Announces Conference Call
8. The Scripps Translational Science Institute Joins The MetaMiner Cardiac Consortium
9. eResearchTechnology, Inc. and nSpire Health, Inc. Form Alliance to Deliver Integrated Cardiac Safety and Pulmonary Clinical Trial Services
10. Australia Chooses Cardiac Science to Equip Its Defence Force
11. Cardiac Science Signs Letter of Intent With Misys Healthcare Systems to Connect With Their EMR Systems
Post Your Comments:
(Date:12/1/2015)... ... December 01, 2015 , ... ... month and Dr. J. Kyle Mathews will join fellow surgeons in ... single site hysterectomy. , An experienced urogynecologist, founder of Plano Urogynecology Associates and ...
(Date:11/30/2015)... (PRWEB) , ... November 30, 2015 , ... Global ... and development stages of a new closed system for isolating adipose-derived stem cells. The ... vascular fraction (SVF) of adipose tissue. SVF is a component of the lipoaspirate obtained ...
(Date:11/30/2015)... (NYSE: BIOA ), a leader in renewable materials, today ... Climate Pledge, alongside more than 140 companies from across the ... demonstrate an ongoing commitment to climate action and to voice ... Paris climate negotiations. Sarnia, Canada ... --> BioAmber uses biotechnology to convert renewable sugars ...
(Date:11/30/2015)... /PRNewswire/ - Zenith Epigenetics Corp. ("Zenith" or the "Company") today ... to its Board of Directors to replace Dr. ... wealth of experience as co-founder of Resverlogix, with expertise in ... --> --> Dr. Wong remarked, "I am ... Zenith,s long standing expertise in epigenetics and the advanced stage ...
Breaking Biology Technology:
(Date:11/2/2015)... PARK, Calif. , Nov. 2, 2015  SRI ... $9 million to provide preclinical development services to the ... the contract, SRI will provide scientific expertise, modern testing ... wide variety of preclinical pharmacology and toxicology studies to ... --> The PREVENT Cancer Drug Development ...
(Date:10/29/2015)... 29, 2015  Rubicon Genomics, Inc., today announced ... of its DNA library preparation products, including the ... ThruPLEX Plasma-seq kit. ThruPLEX Plasma-seq has been optimized ... NGS libraries for liquid biopsies--the analysis of cell-free ... applications in cancer and other conditions. Eurofins Scientific ...
(Date:10/27/2015)... YORK , Oct. 27, 2015 In ... major issues of concern for various industry verticals such ... is due to the growing demand for secure & ... in various ,sectors, such as hacking of bank accounts, ... for electronic equipment such as PC,s, laptops, and smartphones ...
Breaking Biology News(10 mins):